Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 1
2020 2
2021 1
2022 3
2023 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Showing results for B. b amfar
Your search for B. B Aramfar retrieved no results
Global hepatitis C elimination: an investment framework.
Pedrana A, Howell J, Scott N, Schroeder S, Kuschel C, Lazarus JV, Atun R, Baptista-Leite R, 't Hoen E, Hutchinson SJ, Aufegger L, Peck R, Sohn AH, Swan T, Thursz M, Lesi O, Sharma M, Thwaites J, Wilson DP, Hellard M. Pedrana A, et al. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):927-939. doi: 10.1016/S2468-1253(20)30010-8. Epub 2020 Jul 27. Lancet Gastroenterol Hepatol. 2020. PMID: 32730786 Review.
WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have develop …
WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment …
A global investment framework for the elimination of hepatitis B.
Howell J, Pedrana A, Schroeder SE, Scott N, Aufegger L, Atun R, Baptista-Leite R, Hirnschall G, 't Hoen E, Hutchinson SJ, Lazarus JV, Olufunmilayo L, Peck R, Sharma M, Sohn AH, Thompson A, Thursz M, Wilson D, Hellard M. Howell J, et al. J Hepatol. 2021 Mar;74(3):535-549. doi: 10.1016/j.jhep.2020.09.013. Epub 2020 Sep 22. J Hepatol. 2021. PMID: 32971137 Free PMC article.
LAY SUMMARY: Hepatitis B infection is a major cause of death from liver disease and liver cancer globally. To reduce deaths from hepatitis B infection, we need more people to be tested and treated for hepatitis B. In this paper, we outline a framework of acti …
LAY SUMMARY: Hepatitis B infection is a major cause of death from liver disease and liver cancer globally. To reduce deaths from hepa …
An open letter to Gavi: hepatitis B birth dose vaccine can't wait.
CDA Foundation; Coalition for Global Hepatitis Elimination, Hepatitis Australia; Hepatitis Fund; Hepatitis B Foundation, Médecins Sans Frontières Access Campaign; PATH, TREAT Asia/amfAR, The Foundation for AIDS Research, Union for International Cancer Control; World Hepatitis Alliance. Electronic address: contact@worldhepatitisalliance.org. CDA Foundation; Coalition for Global Hepatitis Elimination, Hepatitis Australia, et al. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):115-116. doi: 10.1016/S2468-1253(22)00422-8. Epub 2022 Dec 5. Lancet Gastroenterol Hepatol. 2023. PMID: 36481044 No abstract available.
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system.
Zhao W, Singh K, Sozzi V, Cevaal P, Rossello FJ, Martelotto L, Zerbato JM, Rhodes A, Powell DR, Schröder J, Anderson J, Tumpach C, Fong D, Revill P, Crane M, Grimmond S, Roche M, Audsley J, Lewin SR. Zhao W, et al. Microbiol Spectr. 2025 Sep 2;13(9):e0080925. doi: 10.1128/spectrum.00809-25. Epub 2025 Jul 23. Microbiol Spectr. 2025. PMID: 40698826 Free PMC article.
People with human immunodeficiency virus-hepatitis B virus (HIV-HBV) co-infection have faster rates of liver disease progression and an increase in hepatocellular carcinoma compared to people with HBV mono-infection. ...This study provides new insights into the mechanisms …
People with human immunodeficiency virus-hepatitis B virus (HIV-HBV) co-infection have faster rates of liver disease progression and …
Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R, Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM. Chen M, et al. PLoS One. 2016 Mar 2;11(3):e0150512. doi: 10.1371/journal.pone.0150512. eCollection 2016. PLoS One. 2016. PMID: 26933963 Free PMC article.
BACKGROUND: We assessed the effects of hepatitis B (HBV) or hepatitis C (HCV) co-infection on outcomes of antiretroviral therapy (ART) in HIV-infected patients enrolled in the TREAT Asia HIV Observational Database (TAHOD), a multi-center cohort of HIV-infected patients in …
BACKGROUND: We assessed the effects of hepatitis B (HBV) or hepatitis C (HCV) co-infection on outcomes of antiretroviral therapy (ART …
Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
Schröeder SE, Pedrana A, Scott N, Wilson D, Kuschel C, Aufegger L, Atun R, Baptista-Leite R, Butsashvili M, El-Sayed M, Getahun A, Hamid S, Hammad R, 't Hoen E, Hutchinson SJ, Lazarus JV, Lesi O, Li W, Binti Mohamed R, Olafsson S, Peck R, Sohn AH, Sonderup M, Spearman CW, Swan T, Thursz M, Walker T, Hellard M, Howell J. Schröeder SE, et al. Liver Int. 2019 Oct;39(10):1818-1836. doi: 10.1111/liv.14222. Epub 2019 Sep 4. Liver Int. 2019. PMID: 31433902 Free PMC article. Review.
These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence-gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. ...
These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence-gathering and planning; (b …
Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database.
Aurpibul L, Kariminia A, Vibol U, Fong MS, Le ON, Hansudewechakul R, Bunupuradah T, Kurniati N, Chokephaibulkit K, Kumarasamy N, Wati DK, Yusoff NKN, Razali KAM, Nallusamy RA, Sohn AH, Lumbiganon P; TREAT Asia Pediatric HIV Observational Database (TApHOD) of IeDEA Asia-Pacific. Aurpibul L, et al. Pediatr Infect Dis J. 2018 Aug;37(8):788-793. doi: 10.1097/INF.0000000000001901. Pediatr Infect Dis J. 2018. PMID: 29846357 Free PMC article.
BACKGROUND: Hepatitis B (HBV)-HIV coinfection is associated with liver inflammation, which can progress to liver fibrosis/cirrhosis and hepatocellular carcinoma. ...
BACKGROUND: Hepatitis B (HBV)-HIV coinfection is associated with liver inflammation, which can progress to liver fibrosis/cirrhosis a …
Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific.
Rupasinghe D, Choi JY, Kumarasamy N, Pujari S, Sun LP, Merati TP, Lee MP, Kinh NV, Kiertiburanakul S, Do CD, Avihingsanon A, Ross J, Jiamsakul A; IeDEA Asia-Pacific. Rupasinghe D, et al. HIV Med. 2022 Oct;23(9):959-968. doi: 10.1111/hiv.13280. Epub 2022 Feb 25. HIV Med. 2022. PMID: 35218151 Free PMC article.
This study aims to report the cascade of care (CoC) for hepatitis B (HBV) and C (HCV) among people living with HIV receiving combined antiretroviral therapy (ART). ...
This study aims to report the cascade of care (CoC) for hepatitis B (HBV) and C (HCV) among people living with HIV receiving combined …
High Proportion of Blood-Borne and Sexually Transmitted Infections Among People Deprived of Liberty in a Central Male Prison in Thailand: A Cross-Sectional Study 2018-2019.
Harnpariphan W, Han WM, Supanun R, Ubolyam S, Sophonphan J, Ueaphongsukkit T, Gatechompol S, Tangkijvanich P, Thanprasertsuk S, Khwairakpam G, Ruxrungthan K, Phanuphak P, Matthews GV, Avihingsanon A. Harnpariphan W, et al. AIDS Res Hum Retroviruses. 2022 May;38(5):370-377. doi: 10.1089/AID.2021.0134. Epub 2022 Mar 31. AIDS Res Hum Retroviruses. 2022. PMID: 35262414
We aimed to evaluate the proportion of viral hepatitis B (HBV), hepatitis C (HCV), HIV, and syphilis infections, and factors associated with HCV, HBV, and HIV infection in a central male prison. ...HBV and HCV were defined as positive hepatitis B surface antigen and …
We aimed to evaluate the proportion of viral hepatitis B (HBV), hepatitis C (HCV), HIV, and syphilis infections, and factors associat …
11 results